Ligand Pharmaceuticals Inc $62.90

up +3.16


16/4/2014 04:00 PM  |  NASDAQ : LGND  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get LGND Trend Analysis - it has outperformed the S&P 500 by 129%

Partner Headlines

  1. UPDATE: MLV & Co Reiterates on Ligand Pharmaceuticals Following Strong ...

    Benzinga
  2. Stocks End Near Session Highs; Ligand, Regeneron Jump

    IBD
  3. Ligand Pharmaceuticals Poised For Full-Year Profit

    IBD
  4. UPDATE: Cantor Fitzgerald Raises PT on Ligand Pharmaceuticals as Key Partnered ...

    Benzinga
  5. Ligand Pharmaceuticals Sees Q4 EPS $0.31-$0.32 vs $0.22-$0.24; Q4 Revenue ...

    Benzinga
  6. A Few Stocks Form Bases, But Have Flaws

    IBD
  7. Ligand Pharmaceuticals On Pace For Annual Profit

    IBD
  8. Ligand, NIC: Thinly Traded Stocks That Hold Promise

    IBD
  9. Ligand Partner GSK Receives Marketing Authorization from EC for Additional ...

    Benzinga
  10. Ligand Enters Global License Agreement with CURx Pharmaceuticals for Captisol-Enabled ...

    Benzinga
  11. Ligand Receives FDA Orphan Designation for Captisol-Enabled Topiramate ...

    Benzinga
  12. UPDATE: Cantor Fitzgerald Downgrades Ligand Pharmaceuticals to Hold, Lowers ...

    Benzinga
  13. FDA Accepts NDA for Pfizer, Ligand's Bazedoxifene/Conjugated Estrogens

    Benzinga
  14. Ligand Pharma Begins Pivotal Trial of Captisol-Enabled Propylene Glycol-Free ...

    Benzinga
  15. Ligand Pharmaceuticals, Inc. (LGND) CEO John L Higgins buys 2,000 Shares

    GuruFocus
  16. Benzinga's Volume Movers

    Benzinga
  17. Ligand Pharma, Glaxo Confirm PROMACTA Receives FDA Ok for New Indication

    Benzinga
  18. Ligand Pharmaceuticals Inc. Reports Operating Results (10-K/A)

    GuruFocus
  19. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  20. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  21. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  22. Ligand Pharma Announces Preclinical Data for LG-7501

    Benzinga
  23. Ligand to Receive $2 Million Milestone Payment from Merck; Re-Affirms FY ...

    Benzinga
  24. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  25. Ligand Partner GlaxoSmithKline Announces Priority Review for Supplemental ...

    Benzinga
  26. One Drugmaker Soars, 1 Falls

    IBD
  27. Onyx Up, Celgene Down On Cancer Drug News

    IBD
  28. ConAgra Foods, HONDA MOTOR CO. Among Stocks Up on High Volume Thursday

    FoxBusiness
  29. Ligand Pharmaceuticals Inc. Reports Operating Results (10-K)

    GuruFocus
  30. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  31. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  32. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus
  33. MLV & Co Affirms Ligand Pharmaceuticals Buy, $30 PT

    Benzinga
Trading Center